MediWound Ltd (MDWD) Implied Volatility Current

Tracking MDWD implied volatility helps you identify when options premiums on MediWound Ltd are historically cheap or expensive, and where the best trades are hiding. MediWound Ltd implied volatility reflects the market's expectation of future price movement: when MDWD IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor MediWound Ltd's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For MDWD, tracking metrics like MDWD IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on MDWD signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd.

was founded in 2000 and is headquartered in Yavne, Israel.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where MDWD implied volatility sits today versus where it has been. Our scanner ranks MediWound Ltd implied volatility against its historical range, surfaces extremes in MDWD IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether MediWound Ltd IV is rich or cheap — measure it, then act on it.